Skip to content
2000
Volume 25, Issue 8
  • ISSN: 1566-5240
  • E-ISSN: 1875-5666

Abstract

Thyroid cancer is the most prevalent form of endocrine cancer. Therefore, the administration of new therapeutic agents for thyroid cancer patients is necessary. One of the recent successes in thyroid cancer research is the identification of the role of signaling pathways in the pathogenesis of the disease. Emerging evidence reveals that long non-coding RNAs (lncRNAs) can serve as novel therapeutic approaches for the diagnosis and treatment of thyroid cancer. The lncRNA metastasis-associated lung adenocarcinoma transcript-1 (MALAT1) plays key roles in gene expression, RNA processing, and epigenetic regulation. It is believed that MALAT1 can regulate several cancer-related processes, including tumour cell growth, proliferation, and metastasis. MALAT1 is involved in the pathogenesis of thzroid cancers by targeting multiple downstream targets and miRNA/mRNA axes. Here, we summarize the emerging roles of MALAT1 in this cancer.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cmm/10.2174/0115665240324990241010041445
2024-10-17
2025-10-24

  • From This Site

    /content/journals/cmm/10.2174/0115665240324990241010041445
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Bogović CrnčićT. Ilić TomašM. GirottoN. Grbac IvankovićS. Risk factors for thyroid cancer: What do we know so far?Acta Clin. Croat.202059Suppl. 1667210.20471/acc.2020.59.s1.08 34219886
     [Google Scholar]
  2. ChenD.W. LangB.H.H. McLeodD.S.A. NewboldK. HaymartM.R. Thyroid cancer.Lancet2023401103871531154410.1016/S0140‑6736(23)00020‑X 37023783
     [Google Scholar]
  3. HuangJ. NgaiC.H. DengY. Incidence and mortality of thyroid cancer in 50 countries: A joinpoint regression analysis of global trends.Endocrine202380235536510.1007/s12020‑022‑03274‑7 36607509
     [Google Scholar]
  4. LiM. MasoL.D. VaccarellaS. Global trends in thyroid cancer incidence and the impact of overdiagnosis.Lancet Diabetes Endocrinol.20208646847010.1016/S2213‑8587(20)30115‑7 32445733
     [Google Scholar]
  5. LiM. BritoJ.P. VaccarellaS. Long-term declines of thyroid cancer mortality: An international age–period–cohort analysis.Thyroid202030683884610.1089/thy.2019.0684 31964280
     [Google Scholar]
  6. GoodarziE. MoslemA. FeizhadadH. Epidemiology, incidence and mortality of thyroid cancer and their relationship with the human development index in the world: An ecology study in 2018.Advances in Human Biology201992162167
     [Google Scholar]
  7. BoucaiL. ZafereoM. CabanillasM.E. Thyroid Cancer.JAMA2024331542543510.1001/jama.2023.26348 38319329
     [Google Scholar]
  8. AzizidoostS. GhaedrahmatiF. Sheykhi-SabzehpoushM. The role of LncRNA MCM3AP-AS1 in human cancer.Clin. Transl. Oncol.2022251334710.1007/s12094‑022‑02904‑w 36002764
     [Google Scholar]
  9. BrownJ.A. KinzigC.G. DeGregorioS.J. SteitzJ.A. Methyltransferase-like protein 16 binds the 3′-terminal triple helix of MALAT1 long noncoding RNA.Proc. Natl. Acad. Sci. USA201611349140131401810.1073/pnas.1614759113 27872311
     [Google Scholar]
  10. HuangJ. MaL. SongW. LncRNA‐MALAT1 promotes angiogenesis of thyroid cancer by modulating tumor‐associated macrophage FGF2 protein secretion.J. Cell. Biochem.2017118124821483010.1002/jcb.26153 28543663
     [Google Scholar]
  11. HaoL. WuW. XuY. LncRNA-MALAT1: A key participant in the occurrence and development of Cancer.Molecules2023285212610.3390/molecules28052126 36903369
     [Google Scholar]
  12. JavedZ. Ahmed ShahF. RajabiS. LncRNAs as potential therapeutic targets in thyroid cancer. Asian Pacific journal of cancer prevention.Asian Pac. J. Cancer Prev.202021228128710.31557/APJCP.2020.21.2.281 32102500
     [Google Scholar]
  13. PiórkowskaK. ZygmuntK. HunterW. WróblewskaK. MALAT1: A Long Non-Coding RNA with multiple functions and its role in processes associated with fat deposition.Genes202415447910.3390/genes15040479 38674413
     [Google Scholar]
  14. JiP. DiederichsS. WangW. MALAT-1, a novel noncoding RNA, and thymosin β4 predict metastasis and survival in early-stage non-small cell lung cancer.Oncogene200322398031804110.1038/sj.onc.1206928 12970751
     [Google Scholar]
  15. DjebaliS. DavisC.A. MerkelA. Landscape of transcription in human cells.Nature2012489741410110810.1038/nature11233 22955620
     [Google Scholar]
  16. JohnssonP. LipovichL. GrandérD. MorrisK.V. Evolutionary conservation of long non-coding RNAs; sequence, structure, function.Biochim. Biophys. Acta, Gen. Subj.2014184031063107110.1016/j.bbagen.2013.10.035 24184936
     [Google Scholar]
  17. GuoC. WangX. ChenL-P. Long non-coding RNA MALAT1 regulates ovarian cancer cell proliferation, migration and apoptosis through Wnt/β-catenin signaling pathway.Eur. Rev. Med. Pharmacol. Sci.2018221237033712 29949143
     [Google Scholar]
  18. HutchinsonJ.N. EnsmingerA.W. ClemsonC.M. LynchC.R. LawrenceJ.B. ChessA. A screen for nuclear transcripts identifies two linked noncoding RNAs associated with SC35 splicing domains.BMC Genomics2007813910.1186/1471‑2164‑8‑39 17270048
     [Google Scholar]
  19. KimJ. VenkataN.C. Hernandez GonzalezG.A. KhannaN. BelmontA.S. Gene expression amplification by nuclear speckle association.J. Cell Biol.20202191219 31757787
     [Google Scholar]
  20. WestJ.A. DavisC.P. SunwooH. The long noncoding RNAs NEAT1 and MALAT1 bind active chromatin sites.Mol. Cell201455579180210.1016/j.molcel.2014.07.012 25155612
     [Google Scholar]
  21. SridharB. Rivas-AstrozaM. NguyenT.C. Systematic mapping of RNA-chromatin interactions in vivo.Curr. Biol.201727460260910.1016/j.cub.2017.01.011 28132817
     [Google Scholar]
  22. ArunG. AggarwalD. SpectorD.L. MALAT1 long non-coding RNA: Functional implications.Noncoding RNA2020622210.3390/ncrna6020022 32503170
     [Google Scholar]
  23. ArunG. DiermeierS.D. SpectorD.L. Therapeutic targeting of long non-coding RNAs in cancer.Trends Mol. Med.201824325727710.1016/j.molmed.2018.01.001 29449148
     [Google Scholar]
  24. MalakotiF. TarghazehN. KarimzadehH. Multiple function of lncRNA MALAT1 in cancer occurrence and progression.Chem. Biol. Drug Des.202310151113113710.1111/cbdd.14006 34918470
     [Google Scholar]
  25. BernardD. PrasanthK.V. TripathiV. A long nuclear-retained non-coding RNA regulates synaptogenesis by modulating gene expression.EMBO J.201029183082309310.1038/emboj.2010.199 20729808
     [Google Scholar]
  26. MalakarP. ShiloA. MogilevskyA. Long noncoding RNA MALAT1 promotes hepatocellular carcinoma development by SRSF1 upregulation and mTOR activation.Cancer Res.20177751155116710.1158/0008‑5472.CAN‑16‑1508 27993818
     [Google Scholar]
  27. XiaoW. HalabiR. LinC-H. NazimM. YeomK-H. BlackD.L. The lncRNA Malat1 is trafficked to the cytoplasm as a localized mRNA encoding a small peptide in neurons.bioRxiv20242024.2002
     [Google Scholar]
  28. TripathiV. EllisJ.D. ShenZ. The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation.Mol. Cell201039692593810.1016/j.molcel.2010.08.011 20797886
     [Google Scholar]
  29. EngreitzJ.M. SirokmanK. McDonelP. RNA-RNA interactions enable specific targeting of noncoding RNAs to nascent Pre-mRNAs and chromatin sites.Cell2014159118819910.1016/j.cell.2014.08.018 25259926
     [Google Scholar]
  30. EbrahimiR. ToolabiK. Jannat Ali PourN. Adipose tissue gene expression of long non-coding RNAs; MALAT1, TUG1 in obesity: Is it associated with metabolic profile and lipid homeostasis-related genes expression?Diabetol. Metab. Syndr.20201213610.1186/s13098‑020‑00544‑0 32368256
     [Google Scholar]
  31. EißmannM. GutschnerT. HämmerleM. Loss of the abundant nuclear non-coding RNA MALAT1 is compatible with life and development.RNA Biol.2012981076108710.4161/rna.21089 22858678
     [Google Scholar]
  32. MalakarP. SteinI. SaragoviA. Long noncoding RNA MALAT1 regulates cancer glucose metabolism by enhancing mTOR-mediated translation of TCF7L2.Cancer Res.201979102480249310.1158/0008‑5472.CAN‑18‑1432 30914432
     [Google Scholar]
  33. Sallé-LefortS. MiardS. NolinM.A. Hypoxia upregulates Malat1 expression through a CaMKK/AMPK/HIF-1α axis.Int. J. Oncol.20164941731173610.3892/ijo.2016.3630 27499160
     [Google Scholar]
  34. HuY. LinJ. FangH. Targeting the MALAT1/PARP1/LIG3 complex induces DNA damage and apoptosis in multiple myeloma.Leukemia201832102250226210.1038/s41375‑018‑0104‑2 29632340
     [Google Scholar]
  35. TripathiV. ShenZ. ChakrabortyA. Long noncoding RNA MALAT1 controls cell cycle progression by regulating the expression of oncogenic transcription factor B-MYB.PLoS Genet.201393e100336810.1371/journal.pgen.1003368 23555285
     [Google Scholar]
  36. HandaH. KurodaY. KimuraK. Long non‐coding RNAMALAT 1 is an inducible stress response gene associated with extramedullary spread and poor prognosis of multiple myeloma.Br. J. Haematol.2017179344946010.1111/bjh.14882 28770558
     [Google Scholar]
  37. BhatA.A. AfzalO. AfzalM. MALAT1: A key regulator in lung cancer pathogenesis and therapeutic targeting.Pathol. Res. Pract.202425315499110.1016/j.prp.2023.154991 38070223
     [Google Scholar]
  38. ThapaR. AfzalO. AfzalM. From LncRNA to metastasis: The MALAT1-EMT axis in cancer progression.Pathol. Res. Pract.202425315495910.1016/j.prp.2023.154959 38029713
     [Google Scholar]
  39. LiuJ. AliM.K. MaoY. Emerging role of long non-coding RNA MALAT1 related signaling pathways in the pathogenesis of lung disease.Front. Cell Dev. Biol.202311114949910.3389/fcell.2023.1149499 37250901
     [Google Scholar]
  40. TufailM. The MALAT1-breast cancer interplay: insights and implications.Expert Rev. Mol. Diagn.202323866567810.1080/14737159.2023.2233902 37405385
     [Google Scholar]
  41. PuthanveetilP. ChenS. FengB. GautamA. ChakrabartiS. Long non‐coding RNA MALAT 1 regulates hyperglycaemia induced inflammatory process in the endothelial cells.J. Cell. Mol. Med.20151961418142510.1111/jcmm.12576 25787249
     [Google Scholar]
  42. ShiC. WuL. LiL. LncRNA-MALAT 1 regulates cardiomyocyte scorching in diabetic cardiomyopathy by targeting NLRP3.Cell. Mol. Biol.202267621321910.14715/cmb/2021.67.6.28 35818194
     [Google Scholar]
  43. AlfaifiM. Ali BegM.M. AlshahraniM.Y. Circulating long non-coding RNAs NKILA, NEAT1, MALAT1, and MIAT expression and their association in type 2 diabetes mellitus.BMJ Open Diabetes Res. Care202191e00182110.1136/bmjdrc‑2020‑001821 33436407
     [Google Scholar]
  44. LuJ. GuoJ. LiuJ. MaoX. XuK. Long non-coding RNA MALAT1: A key player in liver diseases.Front. Med. (Lausanne)2022873464310.3389/fmed.2021.734643 35145971
     [Google Scholar]
  45. LaiX. ZhongJ. ZhangA. ZhangB. ZhuT. LiaoR. Focus on long non-coding RNA MALAT1: Insights into acute and chronic lung diseases.Front. Genet.202213100396410.3389/fgene.2022.1003964 36186445
     [Google Scholar]
  46. KhoshnamS.E. MoalemniaA. AnbiyaeeO. FarzanehM. GhaderiS. LncRNA MALAT1 and ischemic stroke: Pathogenesis and opportunities.Mol. Neurobiol.2023 38087169
     [Google Scholar]
  47. NasrolahiA. Khojasteh PourF. Mousavi SalehiA. Potential roles of lncRNA MALAT1-miRNA interactions in ocular diseases.J. Cell Commun. Signal.20231741203121710.1007/s12079‑023‑00787‑2 37870615
     [Google Scholar]
  48. XuY. ZhangQ. LinF. Casiopeina II gly acts on lncRNA MALAT1 by miR 17 5p to inhibit FZD2 expression via the Wnt signaling pathway during the treatment of cervical carcinoma.Oncol. Rep.20194241365137910.3892/or.2019.7268 31524268
     [Google Scholar]
  49. FangD. YangH. LinJ. 17β-Estradiol regulates cell proliferation, colony formation, migration, invasion and promotes apoptosis by upregulating miR-9 and thus degrades MALAT-1 in osteosarcoma cell MG-63 in an estrogen receptor-independent manner.Biochem. Biophys. Res. Commun.2015457450050610.1016/j.bbrc.2014.12.114 25592968
     [Google Scholar]
  50. GuerrieriF. Long non-coding RNAs era in liver cancer.World J. Hepatol.20157161971197310.4254/wjh.v7.i16.1971 26261686
     [Google Scholar]
  51. WuS. SunH. WangY. MALAT1 rs664589 polymorphism inhibits binding to miR-194-5p, contributing to colorectal cancer risk, growth, and metastasis.Cancer Res.201979205432544110.1158/0008‑5472.CAN‑19‑0773 31311811
     [Google Scholar]
  52. LiH. YuanX. YanD. Long non-coding RNA MALAT1 decreases the sensitivity of resistant glioblastoma cell lines to temozolomide.Cell. Physiol. Biochem.20174231192120110.1159/000478917 28668966
     [Google Scholar]
  53. GaoD. LvA. LiH.P. HanD.H. ZhangY.P. LncRNA MALAT‐1 elevates HMGB1 to promote autophagy resulting in inhibition of tumor cell apoptosis in multiple myeloma.J. Cell. Biochem.2017118103341334810.1002/jcb.25987 28295550
     [Google Scholar]
  54. ZhangR. HardinH. HuangW. MALAT1 long non-coding RNA expression in thyroid tissues: Analysis by in situ hybridization and real-time PCR.Endocr. Pathol.201728171210.1007/s12022‑016‑9453‑4 27696303
     [Google Scholar]
  55. LiuJ. DongH. YangY. Upregulation of long noncoding RNA MALAT1 in papillary thyroid cancer and its diagnostic value.Future Oncol.201814293015302210.2217/fon‑2018‑0416 29987950
     [Google Scholar]
  56. WenJ. ChenL. TianH. Effect of MALAT1 polymorphisms on papillary thyroid cancer in a Chinese population.J. Cancer201910235714572110.7150/jca.28887 31788131
     [Google Scholar]
  57. MahdiannasserM. KhazaeiS. Akhavan RahnamaM. Illuminating the role of lncRNAs ROR and MALAT1 in cancer stemness state of anaplastic thyroid cancer: An exploratory study.Noncoding RNA Res.20238345145810.1016/j.ncrna.2023.05.006 37455764
     [Google Scholar]
  58. SamimiH. HaghpanahV. IraniS. Transcript-level regulation of MALAT1-mediated cell cycle and apoptosis genes using dual MEK/Aurora kinase inhibitor “BI-847325” on anaplastic thyroid carcinoma.Daru20192711710.1007/s40199‑018‑0231‑3 31077090
     [Google Scholar]
  59. HuangJ. MaL. SongW. MALAT1 promotes the proliferation and invasion of thyroid cancer cells via regulating the expression of IQGAP1.Biomed. Pharmacother.2016831710.1016/j.biopha.2016.05.039 27470543
     [Google Scholar]
  60. ChuY.H. HardinH. SchneiderD.F. ChenH. LloydR.V. MicroRNA-21 and long non-coding RNA MALAT1 are overexpressed markers in medullary thyroid carcinoma.Exp. Mol. Pathol.2017103222923610.1016/j.yexmp.2017.10.002 29107050
     [Google Scholar]
  61. GouL. ZouH. LiB. Long noncoding RNA MALAT1 knockdown inhibits progression of anaplastic thyroid carcinoma by regulating miR-200a-3p/FOXA1.Cancer Biol. Ther.201920111355136510.1080/15384047.2019.1617567 31500506
     [Google Scholar]
  62. YeM. DongS. HouH. ZhangT. ShenM. Oncogenic role of long noncoding RNAMALAT1 in thyroid cancer progression through regulation of the miR-204/IGF2BP2/m6A-MYC signaling.Mol. Ther. Nucleic Acids20212311210.1016/j.omtn.2020.09.023 33312756
     [Google Scholar]
  63. PengY. FangX. YaoH. ZhangY. ShiJ. MiR-146b-5p regulates the expression of long noncoding RNA MALAT1 and its effect on the invasion and proliferation of papillary thyroid cancer.Cancer Biother. Radiopharm.202136543344010.1089/cbr.2019.3322 32343601
     [Google Scholar]
/content/journals/cmm/10.2174/0115665240324990241010041445
Loading
Exploring the Dual Role of MALAT1 in Thyroid Tumorigenesis: Oncogenic or Tumor Suppressor?
Current Molecular Medicine 25, 1002 (2025); https://doi.org/10.2174/0115665240324990241010041445
/content/journals/cmm/10.2174/0115665240324990241010041445
/content/journals/cmm/10.2174/0115665240324990241010041445
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): Long non-coding RNAs; MALAT1; miRNAs; mRNAs; therapeutic agents; Thyroid cancer

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test